Postnova Analytics GmbH has acquired LS Instruments AG for an undisclosed amount. The transaction brings the Swiss developer of advanced light scattering technology under the ownership of the German analytical instrumentation firm, which specializes in field-flow fractionation systems.
LS Instruments, based in Fribourg, Switzerland, builds and develops sophisticated scientific tools used across biotechnology, pharmaceuticals, food science, cosmetics, and fundamental materials research. The company originated as a spin-off from the Physics Department of the University of Fribourg and has operated from its own facility on Rte-St-Nicolas-de-Flue since 2011. Its core expertise lies in cutting-edge light scattering techniques that address complex measurement needs in both industrial and academic settings.
Postnova Analytics, headquartered in Landsberg, Germany, is known for its work in field-flow fractionation, a separation technology often paired with light scattering detectors for characterizing nanoparticles and macromolecules. The acquisition is strategic because it allows Postnova to integrate LS Instruments’ light scattering hardware directly into its own analytical platforms, reducing reliance on third-party components and strengthening its position in the particle characterization market.
For LS Instruments, joining Postnova provides access to a broader commercial distribution network and established customer base in industrial sectors. The combined entity is expected to offer more complete solutions for researchers and quality control laboratories, particularly in areas where separation and particle sizing are used together. No changes to LS Instruments’ Fribourg operations have been announced, and the company will continue to serve its existing customers under the new ownership.
The acquisition consolidates two complementary technology portfolios under one roof. With Postnova’s separation systems and LS Instruments’ detection capabilities now under common management, the combined company is positioned to deliver integrated workflows for nanomaterial analysis, a segment with growing demand across pharmaceuticals and advanced materials development.